Contractile deficits in engineered cardiac microtissues as a result of MYBPC3 deficiency and mechanical overload
暂无分享,去创建一个
Costas P. Grigoropoulos | Kevin E. Healy | Bruce R. Conklin | Nathaniel Huebsch | Sangmo Koo | B. Conklin | C. Grigoropoulos | K. Healy | M. Mandegar | Zhen Ma | Sangmo Koo | Nathaniel Huebsch | Zhen Ma | Mohammad A. Mandegar | Brian Siemons | Steven Boggess | B. Siemons | Steven C. Boggess
[1] K. McDonald,et al. Hypertrophic Cardiomyopathy in Cardiac Myosin Binding Protein-C Knockout Mice , 2002, Circulation research.
[2] Thomas Eschenhagen,et al. Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice. , 2013, Journal of molecular and cellular cardiology.
[3] George Church,et al. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy , 2015, Science.
[4] B. Cui,et al. Chemically Defined and Small Molecule-Based Generation of Human Cardiomyocytes , 2014, Nature methods.
[5] Deepak Srivastava,et al. Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness , 2015, Proceedings of the National Academy of Sciences.
[6] F. Weinberger,et al. Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice , 2012, Journal of molecular and cellular cardiology.
[7] C. Grigoropoulos,et al. Fabrication of arbitrary polymer patterns for cell study by two-photon polymerization process. , 2009, Journal of biomedical materials research. Part A.
[8] Fu Siong Ng,et al. Processing and analysis of cardiac optical mapping data obtained with potentiometric dyes. , 2012, American journal of physiology. Heart and circulatory physiology.
[9] 遠山 周吾. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes , 2013 .
[10] P. Powers,et al. Dissociation of Structural and Functional Phenotypes in Cardiac Myosin-Binding Protein C Conditional Knockout Mice , 2012, Circulation.
[11] Eduardo Kausel,et al. Integrated Analysis of Contractile Kinetics, Force Generation, and Electrical Activity in Single Human Stem Cell-Derived Cardiomyocytes , 2015, Stem cell reports.
[12] J. Bechhoefer,et al. Calibration of atomic‐force microscope tips , 1993 .
[13] K. McDonald,et al. Loaded Shortening, Power Output, and Rate of Force Redevelopment Are Increased With Knockout of Cardiac Myosin Binding Protein-C , 2003, Circulation research.
[14] Satoshi Kawata,et al. Finer features for functional microdevices , 2001, Nature.
[15] K. Webster,et al. Quantitative Control of Adaptive Cardiac Hypertrophy by Acetyltransferase p300 , 2008, Circulation.
[16] Nathaniel Huebsch,et al. Automated Video-Based Analysis of Contractility and Calcium Flux in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Cultured over Different Spatial Scales. , 2015, Tissue engineering. Part C, Methods.
[17] L. Carrier,et al. Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology. , 2015, Gene.
[18] R. Moss,et al. Cardiac MyBP-C regulates the rate and force of contraction in mammalian myocardium. , 2015, Circulation research.
[19] J. Strande. Haploinsufficiency MYBPC3 mutations: another stress induced cardiomyopathy? Let's take a look! , 2015, Journal of molecular and cellular cardiology.
[20] Nevan J Krogan,et al. CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs. , 2016, Cell stem cell.
[21] Thomas Rau,et al. Human Engineered Heart Tissue as a Versatile Tool in Basic Research and Preclinical Toxicology , 2011, PloS one.
[22] Sean P. Palecek,et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions , 2012, Nature Protocols.
[23] J. Kelly,et al. Pulmonary Hypertension Predicts Mortality and Morbidity in Patients with Dilated Cardiomyopathy , 1992, Annals of Internal Medicine.
[24] Hirofumi Hidai,et al. Self-standing aligned fiber scaffold fabrication by two photon photopolymerization , 2009, Biomedical microdevices.
[25] David L Kaplan,et al. Electrical and mechanical stimulation of cardiac cells and tissue constructs. , 2016, Advanced drug delivery reviews.
[26] M. Gautel,et al. The C-protein (myosin binding protein C) family: regulators of contraction and sarcomere formation? , 1999, Reviews of physiology, biochemistry and pharmacology.
[27] J. Fischer,et al. Elastic Fully Three‐dimensional Microstructure Scaffolds for Cell Force Measurements , 2010, Advanced materials.
[28] K Ann McKibbon,et al. Current status and future prospects. , 2008, Health information and libraries journal.
[29] Christine L. Mummery,et al. Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte Function , 2015, Cell reports.
[30] Eleonora Savio-Galimberti,et al. Electrophysiologic Characterization of Calcium Handling in Human Induced Pluripotent Stem Cell-Derived Atrial Cardiomyocytes , 2018, Stem cell reports.
[31] K. Musunuru. Genome editing of human pluripotent stem cells to generate human cellular disease models , 2013, Disease Models & Mechanisms.
[32] J. Molkentin,et al. The Transcription Factors GATA4 and dHAND Physically Interact to Synergistically Activate Cardiac Gene Expression through a p300-dependent Mechanism* , 2002, The Journal of Biological Chemistry.
[33] A. Hoeft,et al. Myocardial injury modulates the innate immune system and changes myocardial sensitivity , 2006, Basic Research in Cardiology.
[34] M. Suematsu,et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. , 2013, Cell stem cell.
[35] Kam W Leong,et al. Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. , 2011, Biomaterials.
[36] M. Radisic,et al. Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues. , 2016, Advanced drug delivery reviews.
[37] Luke P. Lee,et al. Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications , 2015, Scientific Reports.
[38] Tessa R Werner,et al. Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology. , 2015, Journal of molecular and cellular cardiology.
[39] Kevin E Healy,et al. In vitro cardiac tissue models: Current status and future prospects. , 2016, Advanced drug delivery reviews.
[40] Raymond B. Runyan,et al. Dynamic Myofibrillar Remodeling in Live Cardiomyocytes under Static Stretch , 2016, Scientific Reports.
[41] R. Moss,et al. Neonatal Mouse–Derived Engineered Cardiac Tissue: A Novel Model System for Studying Genetic Heart Disease , 2011, Circulation research.
[42] Kevin E. Healy,et al. Miniaturized iPS-Cell-Derived Cardiac Muscles for Physiologically Relevant Drug Response Analyses , 2016, Scientific Reports.
[43] Gordana Vunjak-Novakovic,et al. Autonomous beating rate adaptation in human stem cell-derived cardiomyocytes , 2016, Nature Communications.
[44] Deepak Srivastava,et al. Multi-Imaging Method to Assay the Contractile Mechanical Output of Micropatterned Human iPSC-Derived Cardiac Myocytes , 2017, Circulation research.
[45] Praveen Shukla,et al. Chemically defined generation of human cardiomyocytes , 2014, Nature Methods.
[46] Kevin Kit Parker,et al. Recapitulating maladaptive, multiscale remodeling of failing myocardium on a chip , 2013, Proceedings of the National Academy of Sciences.
[47] Kumaraswamy Nanthakumar,et al. Design and formulation of functional pluripotent stem cell-derived cardiac microtissues , 2013, Proceedings of the National Academy of Sciences.
[48] Adam J Engler,et al. Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating , 2008, Journal of Cell Science.
[49] D. Warshaw,et al. Molecular Mechanics of Cardiac Myosin-Binding Protein C in Native Thick Filaments , 2012, Science.
[50] K. Node,et al. Endothelin‐1 Induces Myofibrillar Disarray and Contractile Vector Variability in Hypertrophic Cardiomyopathy–Induced Pluripotent Stem Cell–Derived Cardiomyocytes , 2014, Journal of the American Heart Association.
[51] Wesley R. Legant,et al. Microfabricated tissue gauges to measure and manipulate forces from 3D microtissues , 2009, Proceedings of the National Academy of Sciences.
[52] Teodor Gotszalk,et al. Calibration of atomic force microscope , 2008 .
[53] Aibin He,et al. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart , 2011, Proceedings of the National Academy of Sciences.
[54] M. Fujita,et al. Cyclin-dependent Kinase-9 Is a Component of the p300/GATA4 Complex Required for Phenylephrine-induced Hypertrophy in Cardiomyocytes* , 2010, The Journal of Biological Chemistry.
[55] M. Gautel,et al. Isoform transitions of the myosin binding protein C family in developing human and mouse muscles: lack of isoform transcomplementation in cardiac muscle. , 1998, Circulation research.
[56] Euan A Ashley,et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. , 2013, Cell stem cell.
[57] B. Spiegelman,et al. C/EBPβ Controls Exercise-Induced Cardiac Growth and Protects against Pathological Cardiac Remodeling , 2010, Cell.
[58] Thomas Eschenhagen,et al. Increased afterload induces pathological cardiac hypertrophy: a new in vitro model , 2012, Basic Research in Cardiology.
[59] Kevin D. Costa,et al. Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[60] Axel Visel,et al. Dynamic GATA4 enhancers shape the chromatin landscape central to heart development and disease , 2014, Nature Communications.
[61] Nathaniel Huebsch,et al. Three-dimensional filamentous human diseased cardiac tissue model. , 2014, Biomaterials.
[62] R. Beygui,et al. Immunobiology of Fibrin‐Based Engineered Heart Tissue , 2015, Stem cells translational medicine.
[63] Kevin Kit Parker,et al. Structural Phenotyping of Stem Cell-Derived Cardiomyocytes , 2015, Stem cell reports.